Wound Care
The Via(TM) Therapy System is a next-generation negative pressure wound therapy solution. It's light meaning that clinicians and patients can use it as a mobile healing technology. The U.S. Food and Drug Administration cleared V.A.C.Via(TM) in March 2010. It is planned for global launch in the third quarter.
Hydress +Plus™ is a silver based wound dressing. These types of wound dressings work when the moist silver emits ions. Silver ions (Ag+) are bioactive and kill bacteria in both external wounds and in living tissue. The Hydress +Plus™ silver based dressings will be manufactured by AquaMed, yet marketed and sold through HepaLife’s subsidiary called Alliqua BioMedical, Inc. ...
Read More...
The latest MEDIHONEY line extension is dispensed from a tube and is made of Active Manuka honey (Leptospermum) that is blended with a natural-based gelling agent.
REVIVE is constructed of a proprietary material called Biomerix Biomaterial™ which is a biointegrative synthetic tissue scaffold. The structure is designed to play a role similar to that of the body's own extracellular matrix, supporting organized tissue ingrowth. The device is designed for repair and reinforcement in a variety of soft tissue procedures such as inguinal ...
Read More...
2275 Research Blvd. Suite 500, Rockville, MD, 20850, USA
(from website) Glycotex is a U.S. based development stage biopharmaceutical company focused on discovering and developing therapies intended to accelerate human wound healing and tissue repair across a wide range of human applications. GLYC-101 is a topical gel to be applied directly on the wound surface. GLYC-101 is intended to stimulate and modulate the natural cascade of wound ...
Read More...
Terrington House 13-15 Hills Road, Cambridge, CB2 1NL, United Kingdom
(from website) Avita Medical Limited is a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH). The company develops and distributes highly innovative products in Regenerative and Respiratory Medicine. The company's regenerative and tissue-engineered products provide revolutionary solutions utilising the patient's own skin and the re ...
Read More...
Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process. It is FDA approved to treat diabetic foot ulcers and is the focus of an ongoing pivotal trial in subjects with venous leg ulcers (VLUs) to assess the product’s safety and efficacy in the promotion of healing VLUs. To date, nearly 200,000 applicatio ...
Read More...
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is managed by Consolidated Computing Pty Ltd.